Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors
NCT04647227Phase 4Recruiting
- Sponsor
- American Thrombosis and Hemostasis Network
- Start
- Jun 2021
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by American Thrombosis and Hemostasis Network. Started Jun 2021; status: recruiting.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT04647227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04647227.